Learn how stool appearance can signal colon cancer. Recognize signs like ribbon-like and pebble-shaped stools, and understand ...

Last year, the Food and Drug Administration approved the first at-home test that can detect three common infections in women ...

Scientists have discovered that collecting stool samples at home is as life-saving as invasive colonoscopy procedures.

FIT checks for blood in the stool, which can indicate the presence of colorectal cancer or polyps. Patients collect stool ...

Consumers simply prick a finger, place a drop of blood on a sample card, sealed into an envelope (provided) and mail it to ...

There is a great deal of excitement around microbiome research as it confirms, and debunks, long-held beliefs. Investigators have shown, for example, that proton-pump inhibitors can alter the ...

Chicago, IL–based healthcare technology giant Abbott Laboratories will acquire Exact Sciences for $23 billion. Exact’s flagship product, Cologuard, is an at-home, stool-based test approved by the FDA ...

Exact Sciences' new launches and big ambitions in the cancer market make it an exciting long-term pick. Roku turned a profit for the first time in years, showing that the streaming platform's strategy ...

I’ve dealt with chronic indigestion, painful burps, reflux, and bloating for the past 15 years. In 2010, I underwent a range of diagnostic tests—a colonoscopy, an endoscopy, a gastric emptying test, ...

Tens of millions of middle-aged and older Americans haven’t gotten their recommended checks for early signs of potential colon cancer, either through the “gold standard” of colonoscopy or a ...

Exact Sciences' most important product is driving solid revenue growth. It has launched several others that could help boost sales and jolt the stock. The company's long-term prospects look attractive ...